TCS, HDFCBANK, SBI Liquid Fund (G)
Solara Active Pharma Sciences Ltd.
Solara Active Pharma
NSE
₹ 0.00
0.00 (0.00)%
Healthcare
Small-cap
With a market cap of ₹18.90L Cr.
Moderate Volatility
Stock is 1.13x as volatile as index
| EX-Date | Purpose |
|---|---|
| 06 05 2021 | Dividend & Audited Results |
| 04 08 2021 | Quarterly Results |
| 11 11 2021 | Quarterly Results |
| 09 02 2022 | Quarterly Results |
| 29 04 2022 | Dividend & Audited Results |
| 04 08 2022 | Quarterly Results |
| 09 11 2022 | Quarterly Results |
| 25 01 2023 | Quarterly Results |
| 12 05 2023 | Audited Results |
| 05 07 2023 | Right Issue of Equity Shares |
| 11 08 2023 | Quarterly Results |
| 14 08 2023 | Quarterly Results (Revised) |
| 14 11 2023 | Quarterly Results |
| 14 02 2024 | Quarterly Results |
| 21 10 2024 | Quarterly Results |
| 24 01 2025 | Quarterly Results |
| 26 03 2025 | Inter alia, to consider and approve :- a) To consider and approve, a proposal of making First Call on 1,19,98,755 partly paid-up Equity Shares, having a face value of Rs.10/- each (Rs.3.50/- paid-up) issued by the Company on rights basis in accordance with the Letter of Offer dated May 09, 2024. b) Any other matters, which may be incidental and ancillary to making aforesaid first call. |
| 02 04 2025 | Inter-alia, to consider and approve:- (1) the First Call money Notice, on the partly paid Equity Shares issued on Rights basis which is to be sent to the eligible Shareholders |
News
No News data available
